General

Cell Line

hPSCreg name WAe009-A-P
Cite as:
WAe009-A-P (RRID:CVCL_C9J7)
Cell line type Human embryonic stem cell (hESC)
Similar lines
WAe009-A
(WA09, H9)
Donor diseases:
Huntington's disease
WAe009-A-1P
(IsoHD-30Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1Q
(IsoHD-65Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1R
(IsoHD-81Q-NGN2)
Donor diseases:
Huntington's disease
WAe009-A-1H
(MYL3-KO)
Donor diseases:
Huntington's disease
WAe009-A-1I
(H9::GFP cyto-reporter line)
Donor diseases:
Huntington's disease
WAe009-A-1J
(H9::mcherry cyto-reporter line)
Donor diseases:
Huntington's disease
WAe009-A-R
(H9-NRL-GP, WA09 NRL+/eGFP)
Donor diseases:
Huntington's disease
WAe009-A-36
(JPH2-KO)
Donor diseases:
Huntington's disease
WAe009-A-12
(H9_RB1ex3_C7)
Donor diseases:
Huntington's disease
WAe009-A-13
(H9_RB1ex3_G12LS)
Donor diseases:
Huntington's disease
WAe009-A-1E
(TBX20-KO)
Donor diseases:
Huntington's disease
WAe009-A-37
(H9-GSX2-tTA:GFP)
Donor diseases:
Huntington's disease
WAe009-A-58
(COL4A5 heterozygote)
Donor diseases:
Huntington's disease
WAe009-A-59
(dHAND KO)
Donor diseases:
Huntington's disease
WAe009-A-60
(H9 iNK5A)
Donor diseases:
Huntington's disease
WAe009-A-77
(H9-GFP)
Donor diseases:
Huntington's disease
WAe009-A-78
(TBX18-KO)
Donor diseases:
Huntington's disease
WAe009-A-7
(H9-mHOXA9)
Donor diseases:
Huntington's disease
WAe009-A-99
(dCas9-p300 H9 21)
Donor diseases:
Huntington's disease
WAe009-A-62
(KCNQ1 KO)
Donor diseases:
Huntington's disease
Last update 11th May 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator The Second Affiliated Hospital of Zhengzhou University (ZZUSAH)
Owner The Second Affiliated Hospital of Zhengzhou University (ZZUSAH)

External Databases

BioSamples SAMEA113425361
Cellosaurus CVCL_C9J7
Wikidata Q123033864

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex female
Ethnicity N/A

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • HD
  • Huntington disease
  • Huntington's chorea
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA7768918

Ethics

Also have a look at the ethics information for the parental line WAe009-A .

hESC Derivation

The source cell information can be found in the parental cell line WAe009-A.

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SSEA-4
Yes
NANOG
Yes
POU5F1 (OCT-4)
Yes
Score:
Marker Present Absent
mCpG
OCT4
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
alpha fetoprotein
Yes
RBFOX2
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
ACTA2
Yes
NKX2-5
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
NeuN
Yes
β3-Tubulin
Yes
Morphology

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Genetic modifications
FLNA (target)
Gene knock-out
Xp28
CRISPR-associated (CRISPR/Cas) System